Novel coronavirus fusion epitope antigen, urine antibody testing device and application thereof
The invention provides a novel coronavirus fusion epitope antigen, a urine antibody testing device and application thereof. Through deep research and screening, the invention discloses a novel universal fusion epitope protein for the coronavirus (SARS-CoV-2), and the novel universal fusion epitope p...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG WEIPING SHOU YINGJIA HUA SHAOBING CAI LINYAN YING JIANJUN HAN BIN ZHU YIQING MIAO WEIJIE |
| description | The invention provides a novel coronavirus fusion epitope antigen, a urine antibody testing device and application thereof. Through deep research and screening, the invention discloses a novel universal fusion epitope protein for the coronavirus (SARS-CoV-2), and the novel universal fusion epitope protein reacts with antibodies generated after infection of various variant strains. In the invention, the fusion epitope protein is also used as an antigen for detecting the SARS-CoV-2 virus antibody, a novel detection device (test pen) for detecting the coronavirus urine sample antibody is prepared, urine is sampled noninvasively, and the fusion epitope protein has obvious advantages in the aspects of operation and biological safety.
本发明提供了新型冠状病毒融合表位抗原、尿液抗体测试装置及其应用。经过深入的研究筛选，本发明揭示一种新型冠状病毒(SARS-CoV-2)通用融合表位蛋白，与各变异株感染后产生的抗体均有反应。本发明中，还以所述融合表位蛋白作为检测SARS-CoV-2病毒抗体的抗原，制备了一种新型冠状病毒尿样抗体检测的检测装置(测试笔)，尿液为无创取样，在操作和生物安全方面具有明显优势。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116577503A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116577503A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116577503A3</originalsourceid><addsrcrecordid>eNqNizEKwkAQRdNYiHqHsVcwhJhagmKVyj6sm584EGaW3UnA20vQA1h93uP9ddY2OmMkr1HFzRynRP2UWIUQ2DSAnBgPkANNkeWLT-3eZEjGMlCHmf3iO3IhjOydLXd7IUL7bbbq3Ziw--0m29-uj_p-RNAWKTgPgbV1k-fnsqrKU3Ep_mk-5N49pg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Novel coronavirus fusion epitope antigen, urine antibody testing device and application thereof</title><source>esp@cenet</source><creator>WANG WEIPING ; SHOU YINGJIA ; HUA SHAOBING ; CAI LINYAN ; YING JIANJUN ; HAN BIN ; ZHU YIQING ; MIAO WEIJIE</creator><creatorcontrib>WANG WEIPING ; SHOU YINGJIA ; HUA SHAOBING ; CAI LINYAN ; YING JIANJUN ; HAN BIN ; ZHU YIQING ; MIAO WEIJIE</creatorcontrib><description>The invention provides a novel coronavirus fusion epitope antigen, a urine antibody testing device and application thereof. Through deep research and screening, the invention discloses a novel universal fusion epitope protein for the coronavirus (SARS-CoV-2), and the novel universal fusion epitope protein reacts with antibodies generated after infection of various variant strains. In the invention, the fusion epitope protein is also used as an antigen for detecting the SARS-CoV-2 virus antibody, a novel detection device (test pen) for detecting the coronavirus urine sample antibody is prepared, urine is sampled noninvasively, and the fusion epitope protein has obvious advantages in the aspects of operation and biological safety.
本发明提供了新型冠状病毒融合表位抗原、尿液抗体测试装置及其应用。经过深入的研究筛选，本发明揭示一种新型冠状病毒(SARS-CoV-2)通用融合表位蛋白，与各变异株感染后产生的抗体均有反应。本发明中，还以所述融合表位蛋白作为检测SARS-CoV-2病毒抗体的抗原，制备了一种新型冠状病毒尿样抗体检测的检测装置(测试笔)，尿液为无创取样，在操作和生物安全方面具有明显优势。</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PHYSICS ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; TESTING ; VINEGAR ; WINE</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230811&DB=EPODOC&CC=CN&NR=116577503A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230811&DB=EPODOC&CC=CN&NR=116577503A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG WEIPING</creatorcontrib><creatorcontrib>SHOU YINGJIA</creatorcontrib><creatorcontrib>HUA SHAOBING</creatorcontrib><creatorcontrib>CAI LINYAN</creatorcontrib><creatorcontrib>YING JIANJUN</creatorcontrib><creatorcontrib>HAN BIN</creatorcontrib><creatorcontrib>ZHU YIQING</creatorcontrib><creatorcontrib>MIAO WEIJIE</creatorcontrib><title>Novel coronavirus fusion epitope antigen, urine antibody testing device and application thereof</title><description>The invention provides a novel coronavirus fusion epitope antigen, a urine antibody testing device and application thereof. Through deep research and screening, the invention discloses a novel universal fusion epitope protein for the coronavirus (SARS-CoV-2), and the novel universal fusion epitope protein reacts with antibodies generated after infection of various variant strains. In the invention, the fusion epitope protein is also used as an antigen for detecting the SARS-CoV-2 virus antibody, a novel detection device (test pen) for detecting the coronavirus urine sample antibody is prepared, urine is sampled noninvasively, and the fusion epitope protein has obvious advantages in the aspects of operation and biological safety.
本发明提供了新型冠状病毒融合表位抗原、尿液抗体测试装置及其应用。经过深入的研究筛选，本发明揭示一种新型冠状病毒(SARS-CoV-2)通用融合表位蛋白，与各变异株感染后产生的抗体均有反应。本发明中，还以所述融合表位蛋白作为检测SARS-CoV-2病毒抗体的抗原，制备了一种新型冠状病毒尿样抗体检测的检测装置(测试笔)，尿液为无创取样，在操作和生物安全方面具有明显优势。</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PHYSICS</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>TESTING</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNizEKwkAQRdNYiHqHsVcwhJhagmKVyj6sm584EGaW3UnA20vQA1h93uP9ddY2OmMkr1HFzRynRP2UWIUQ2DSAnBgPkANNkeWLT-3eZEjGMlCHmf3iO3IhjOydLXd7IUL7bbbq3Ziw--0m29-uj_p-RNAWKTgPgbV1k-fnsqrKU3Ep_mk-5N49pg</recordid><startdate>20230811</startdate><enddate>20230811</enddate><creator>WANG WEIPING</creator><creator>SHOU YINGJIA</creator><creator>HUA SHAOBING</creator><creator>CAI LINYAN</creator><creator>YING JIANJUN</creator><creator>HAN BIN</creator><creator>ZHU YIQING</creator><creator>MIAO WEIJIE</creator><scope>EVB</scope></search><sort><creationdate>20230811</creationdate><title>Novel coronavirus fusion epitope antigen, urine antibody testing device and application thereof</title><author>WANG WEIPING ; SHOU YINGJIA ; HUA SHAOBING ; CAI LINYAN ; YING JIANJUN ; HAN BIN ; ZHU YIQING ; MIAO WEIJIE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116577503A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PHYSICS</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>TESTING</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG WEIPING</creatorcontrib><creatorcontrib>SHOU YINGJIA</creatorcontrib><creatorcontrib>HUA SHAOBING</creatorcontrib><creatorcontrib>CAI LINYAN</creatorcontrib><creatorcontrib>YING JIANJUN</creatorcontrib><creatorcontrib>HAN BIN</creatorcontrib><creatorcontrib>ZHU YIQING</creatorcontrib><creatorcontrib>MIAO WEIJIE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG WEIPING</au><au>SHOU YINGJIA</au><au>HUA SHAOBING</au><au>CAI LINYAN</au><au>YING JIANJUN</au><au>HAN BIN</au><au>ZHU YIQING</au><au>MIAO WEIJIE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Novel coronavirus fusion epitope antigen, urine antibody testing device and application thereof</title><date>2023-08-11</date><risdate>2023</risdate><abstract>The invention provides a novel coronavirus fusion epitope antigen, a urine antibody testing device and application thereof. Through deep research and screening, the invention discloses a novel universal fusion epitope protein for the coronavirus (SARS-CoV-2), and the novel universal fusion epitope protein reacts with antibodies generated after infection of various variant strains. In the invention, the fusion epitope protein is also used as an antigen for detecting the SARS-CoV-2 virus antibody, a novel detection device (test pen) for detecting the coronavirus urine sample antibody is prepared, urine is sampled noninvasively, and the fusion epitope protein has obvious advantages in the aspects of operation and biological safety.
本发明提供了新型冠状病毒融合表位抗原、尿液抗体测试装置及其应用。经过深入的研究筛选，本发明揭示一种新型冠状病毒(SARS-CoV-2)通用融合表位蛋白，与各变异株感染后产生的抗体均有反应。本发明中，还以所述融合表位蛋白作为检测SARS-CoV-2病毒抗体的抗原，制备了一种新型冠状病毒尿样抗体检测的检测装置(测试笔)，尿液为无创取样，在操作和生物安全方面具有明显优势。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116577503A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
| title | Novel coronavirus fusion epitope antigen, urine antibody testing device and application thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A09%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20WEIPING&rft.date=2023-08-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116577503A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |